(Reuters) - Pfizer intends to sell about 700 million ordinary shares in Haleon, cutting its stake to about 7.3% in the British consumer healthcare group, a bookrunner said on Tuesday.
(Reporting by Aatrayee Chatterjee; Editing by Shailesh Kuber)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.74 USD | -0.35% |
|
-2.94% | -2.98% |
Feb. 07 | AbbVie Gets FDA Approval of Intravenous Antibiotic Emblaveo | DJ |
Feb. 07 | US FDA approves AbbVie-Pfizer's treatment for intra-abdominal infections | RE |
(Reuters) - Pfizer intends to sell about 700 million ordinary shares in Haleon, cutting its stake to about 7.3% in the British consumer healthcare group, a bookrunner said on Tuesday.
(Reporting by Aatrayee Chatterjee; Editing by Shailesh Kuber)
Price |
Change |
5d. change |
Capi. | ||
---|---|---|---|---|---|
379.40GBX | +0.37% | +1.25% | 42.6B | ||
25.74USD | -0.35% | -2.94% | 146B | ||